XFOR Annual Accounts Payable
$8.95 M
+$1.17 M+15.04%
31 December 2023
Summary:
As of January 23, 2025, XFOR annual accounts payable is $8.95 million, with the most recent change of +$1.17 million (+15.04%) on December 31, 2023. During the last 3 years, it has risen by +$5.80 million (+184.57%). XFOR annual accounts payable is now at all-time high.XFOR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XFOR Quarterly Accounts Payable
$8.58 M
+$591.00 K+7.40%
30 September 2024
Summary:
As of January 23, 2025, XFOR quarterly accounts payable is $8.58 million, with the most recent change of +$591.00 thousand (+7.40%) on September 30, 2024. Over the past year, it has increased by +$591.00 thousand (+7.40%). XFOR quarterly accounts payable is now -4.14% below its all-time high of $8.95 million, reached on December 31, 2023.XFOR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XFOR Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.0% | +7.4% |
| 3 y3 years | +184.6% | +7.4% |
| 5 y5 years | +1541.7% | +403.4% |
XFOR Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +108.9% | -4.1% | +140.3% |
| 5 y | 5-year | at high | +328.5% | -4.1% | +587.3% |
| alltime | all time | at high | +2015.1% | -4.1% | +1473.8% |
X4 Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.58 M(+7.4%) |
| June 2024 | - | $7.99 M(-10.6%) |
| Mar 2024 | - | $8.94 M(-0.1%) |
| Dec 2023 | $8.95 M(+15.0%) | $8.95 M(+10.0%) |
| Sept 2023 | - | $8.13 M(+59.2%) |
| June 2023 | - | $5.11 M(-14.8%) |
| Mar 2023 | - | $5.99 M(-23.0%) |
| Dec 2022 | $7.78 M(+81.6%) | $7.78 M(+104.7%) |
| Sept 2022 | - | $3.80 M(+3.3%) |
| June 2022 | - | $3.68 M(+3.0%) |
| Mar 2022 | - | $3.57 M(-16.7%) |
| Dec 2021 | $4.28 M(+36.2%) | $4.28 M(+76.7%) |
| Sept 2021 | - | $2.42 M(-4.1%) |
| June 2021 | - | $2.53 M(-18.2%) |
| Mar 2021 | - | $3.09 M(-1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $3.14 M(+50.6%) | $3.14 M(-19.2%) |
| Sept 2020 | - | $3.89 M(+111.7%) |
| June 2020 | - | $1.84 M(+47.3%) |
| Mar 2020 | - | $1.25 M(-40.2%) |
| Dec 2019 | $2.09 M(+283.1%) | $2.09 M(+22.5%) |
| Sept 2019 | - | $1.70 M(-45.0%) |
| June 2019 | - | $3.10 M(-49.5%) |
| Mar 2019 | - | $6.13 M(+1025.1%) |
| Dec 2018 | $545.00 K(-71.2%) | $545.00 K(-74.4%) |
| Sept 2018 | - | $2.13 M(-0.5%) |
| June 2018 | - | $2.14 M(+92.9%) |
| Mar 2018 | - | $1.11 M(-41.5%) |
| Dec 2017 | $1.89 M(+15.1%) | $1.89 M(-54.5%) |
| Sept 2017 | - | $4.16 M(+153.1%) |
| Dec 2016 | $1.65 M(+288.9%) | $1.65 M |
| Dec 2015 | $423.00 K | - |
FAQ
- What is X4 Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual accounts payable year-on-year change?
- What is X4 Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly accounts payable year-on-year change?
What is X4 Pharmaceuticals annual accounts payable?
The current annual accounts payable of XFOR is $8.95 M
What is the all time high annual accounts payable for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual accounts payable is $8.95 M
What is X4 Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, XFOR annual accounts payable has changed by +$1.17 M (+15.04%)
What is X4 Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of XFOR is $8.58 M
What is the all time high quarterly accounts payable for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly accounts payable is $8.95 M
What is X4 Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, XFOR quarterly accounts payable has changed by +$591.00 K (+7.40%)